Elsevier: Data empowerment "evidence-based medicine"

Western medicine is evidence-based medicine, finding scientific and effective evidence, and giving effective diagnosis and treatment according to scientific rules of diagnosis and treatment is the key to the application of evidence-based medicine. The rise of AI and big data allows doctors to more effectively discover new evidence and obtain scientific and effective rules for diagnosis and treatment. In this context, how can we use the data to make data contribute to medical development? Mr. Lin Guoqing, President of Elsevier Greater China, introduced Elsevier's data empowerment in an interview with HC3i.

Pay attention to the data and release more "proofs" that can be "followed"

Elsevier is one of the world's largest providers of scientific and medical medical information and solutions, including high-level publications such as The Lancet and Cell, and several web-based academics such as ScienceDirector, Scopus, and SciVal. Database and research solutions. A total of 350,000 papers are published each year in the journals published by Elsevier, and only ScienceDirect has an annual download of 1 billion.

Is it possible to lead the future medical development with a treasure trove of medical knowledge?

Sleeping medical knowledge is only used for personal reference, and support for clinical research is not enough. Using modern information technology, based on big data analysis and AI, Elsevier has developed a series of clinical research solutions to provide comprehensive support in the areas of clinical decision-making, drug decision-making, and personnel training.

“Elsevier focuses on helping healthcare professionals improve their clinical outcomes through evidence-based medicine.” Mr. Lin Guoqing said, “In the high-speed development of medical science worldwide, we hope to contribute to the development of medical institutions at home and abroad.” Elsevier It has been transformed from a publisher to a medical science and technology information analysis company. How to use authoritative content and technology to create new solutions to help medical research is the current and future direction of Elsevier.

Fun data, activate medical technology ecology

Authoritative medical content is very important for all aspects of the medical technology industry chain. In the era of big data, different companies participate in different stages of technological development and need knowledge to help them process value. The knowledge contained in medical data is related to life health, especially the need for authoritative, scientifically based data and data as a basis for treatment.

“Elsevier hopes to provide reliable support for the medical community from both the 'circulation' and 'certificate' aspects.” Mr. Lin Guoqing said that on the one hand, the content provided by Elsevier is peer-reviewed, whether it is medical technology. For enterprises and medical research institutions, the “certificate” provided is very reliable. On the other hand, in the application of science and technology, Elsevier relies on the power of science and technology to make clinical research work more efficient and accurate, so as to continuously improve the ability to "follow".

Based on the strong foundation of “certificate” to accelerate the ability to “follow”, it is the direction of Elsevier's continuous efforts, and has achieved productization in multiple dimensions, providing efficient and reliable products for medical teaching and research users. At present, Elsevier has launched three major areas of medical, teaching and research solutions, including: hospitals, universities, government research institutions, pharmaceutical companies and other aspects of coverage of medical services.

First, Elsevier's solutions in the medical field are oriented to doctors and hospitals. Among them, the doctor-oriented solution has ClinicalKey, which provides medical reference. It helps doctors to easily find and apply relevant knowledge by simulating user thinking and working methods. At the hospital level, it helps hospitals to better control medical costs by reducing medical differences, allowing hospitals to pass Unified disease diagnosis and treatment path reduces treatment costs. In addition, the iPRC smart trial solution can help hospitals control the cost of medications in a zero-plus environment, allowing pharmacists to monitor drug safety and costs.

Second, Elsevier provides a wealth of support in medical education. For example, by providing high-quality books and reference materials, students and faculty members can achieve outstanding clinical education results. ClinicalKey Medical Education provides students with more basic reference materials to help students better match the content of the school.

Again, research is another task for doctors and an important way for hospital development. Elsevier's Scopus, SciVal, etc. can help hospitals and colleges fully understand their own scientific research strength, and are more targeted in the standard, providing a basis for the next development and competition.

Finally, interdisciplinary development has become the mainstream of current clinical research development. Whether it is disease research or clinical diagnosis, clinical researchers need not only medical knowledge, but also biomedical knowledge such as new drug development. Elsevier solutions also help pharmaceutical companies to find new targets for drug discovery and optimize drug synthesis. Shorten the drug development cycle and accelerate the application of research and development results. From pharmaceutical research and development, clinical research, to process management and medical personnel training, help medical institutions to establish an efficient, innovative ecological environment for industry-university-research cooperation.

Take precautions and seize new opportunities in precision medicine

Since Obama proposed the "Precision Medical" program in the US Congress report in 2016, precision medicine is rapidly becoming a hot spot in the world. According to research reports, the global precision medical market is expected to grow at an annual rate of 15%. By 2026, the global precision medical market will exceed $140 billion. The rise of precision medicine is also illuminating hope for Chinese medical practitioners. The Chinese medical community hopes to seize the opportunity of precision medical care to lead China's medical advancement.

Precision medicine is an emerging approach to disease prevention and treatment that takes into account differences in personal genetics, environment and lifestyle, and its advancement relies on a richer chain of evidence. The rise of informatization has made China's medical data grow rapidly. Under the combined effect of advanced computing power, cutting-edge platform computing, and genetic and biological research, it is creating conditions for the rise of precision medicine.

“To fully exploit the evidence and use it scientifically, it will speed up the pace of precision medicine. Medical personnel need reliable and available tools to achieve the integration and utilization of various types of evidence.” Mr. Lin Guoqing said that Elsevier is constantly accelerating its products. At the same time of research and development, in-depth study of the working habits of Chinese medical institutions users, not only from the product side to fully localize, but also reserved a flexible space for product design, allowing customers to participate in the design of products according to their own needs, Fully meet the individual needs of the hospital's current and future development.

Elsevier promotes medical development in China with technology

China's investment in hospital informationization and science and education platform construction is increasing, and the construction results in a short period of one year are very significant. Looking back over the past few years, the development of China's medical technology is not a linear growth trend. Once the meridians open up medical innovation breakthroughs, the progress will be rapid. This is a distinctive feature of the development of medical technology in China.

Mr. Lin Guoqing is full of expectations for the development of China's medical technology. He said that the favorable policies and the integration of technology and resources will enable China's medical technology to develop at a high speed, which will also bring growth space for countless medical technology companies. As one of them, Elsevier hopes to provide multi-dimensional support from data, consulting, technology and model to the whole ecological development, and work together with partners to promote the development of China's medical technology.

(Author: Yincong Ying)

Ginger

Product category of Fresh Ginger;We are a professional manufacturer from China, fresh ginger, air-dried ginger supplier/factory, wholesale high-quality fresh ginger research and development and manufacturing products, our company mainly processing and exporting ginger, perennial processing and sales export air-dried ginger, fresh ginger, specification: 50g, 150g, 250g, 300g, 350g.There are calcium plastic boxes, boxes and mesh bags. Our company has its own factory below. There is an assembly line of ginger washing equipment.We have perfect after - sales service and technical support.Looking forward to your cooperation!

High Quality Ginger

Tender Ginger,Fresh Tender Ginger,New Crop Ginger,Organic Fresh Ginger

Jining Sunagro Trade Co., Ltd. , https://www.sunagro-food.com